While the trial met its primary endpoint, the FDA stated in its letter that the application could not be approved in its current form.

HealthDay News — Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are associated with a reduced risk for autoimmune rheumatic diseases compared with sulfonylureas among adults with type 2 diabetes, ...

Odds of delirium up 41% for patients admitted to physicians in the highest versus lowest quartile of first-generation antihistamine prescribing.

The Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory ...

Notably, in a post-hoc analysis which included adolescents who were diagnosed with severe AA less than 2 years before starting treatment, successful hair regrowth at 1 year was achieved in 80% and ...

Recurrence-free survival was numerically higher with adjuvant pembrolizumab, but difference was not significant.

HealthDay News — A growing measles outbreak along the Utah-Arizona border has spread to nearby communities, making it the nation’s second-largest this year, health officials confirmed.

HealthDay News — Vaccination against herpes zoster (HZ) is associated with lower risks for heart disease, dementia, and mortality among adults aged 50 years and older, according to a study presented ...

The contaminated eggs came from Black Sheep Egg Company’s Arkansas processing plant and were distributed in Arkansas, Missouri and potentially other states ...

HealthDay News — For patients with inflammatory bowel disease (IBD), alterations in gut microbiota are associated with health-related quality of life (HRQoL) outcomes, according to a study published ...

“For over a decade, and as recently as August, FDA has fully evaluated the emerging scientific evidence and repeatedly concluded that the data do not support a causal association between acetaminophen ...

Topline results were announced from a phase 3 study evaluating Moderna’s cytomegalovirus (CMV) vaccine candidate, mRNA-1647.